JSPR
Jasper Therapeutics Inc
NASDAQ: JSPR · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.13% today
Updated 2026-04-30
Market cap
$26.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.95
Dividend yield
—
52W range
$1 – $7
Volume
0.4M
Jasper Therapeutics Inc (JSPR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-230.30%
ROA
-88.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-4.99M | — | — | — |
| 2020 | $0.00 | $-31.67M | — | — | — |
| 2021 | $6.20M | $-30.64M | -9.13% | -594.46% | -494.46% |
| 2022 | $13.51M | $-37.69M | -9.70% | -378.92% | -278.92% |
| 2023 | $0.00 | $-64.47M | — | — | — |
| 2024 | $0.00 | $-71.27M | — | — | — |
| 2025 | $0.00 | $-75.80M | — | — | — |